Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
57,393.60
54,218.00
37,672.00
67,138.00
5,285.00
33,867
Depreciation, Depletion & Amortization
1,347.30
1,095.00
1,299.00
1,408.00
6,118.00
5,897
Other Funds
-
72,744.00
6.00
-
-
9,651
Funds from Operations
50,604.00
32,136.00
21,624.00
50,402.00
14,469.00
18,279
Changes in Working Capital
9,498.80
3,303.00
17,892.00
3,580.00
17,982.00
6,284
Net Operating Cash Flow
60,102.80
28,833.00
3,732.00
53,982.00
32,451.00
24,563
Capital Expenditures
76.90
1,603.00
701.00
405.00
11.00
Net Investing Cash Flow
76.90
1,603.00
701.00
405.00
5,864.00
Issuance/Reduction of Debt, Net
19,758.90
7,333.00
16,799.00
-
27,052.00
Net Financing Cash Flow
20,166.20
77,732.00
17,521.00
2,846.00
27,491.00
Net Change in Cash
40,013.50
47,296.00
13,088.00
51,541.00
10,824.00
Free Cash Flow
60,179.70
30,436.00
4,433.00
54,387.00
32,462.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
15,972.00
40
Net Assets from Acquisitions
-
-
-
-
5,853.00
Change in Capital Stock
407.30
12,321.00
716.00
2,846.00
439.00

About BioDelivery Sciences International

View Profile
Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.